Robeco Institutional Asset Management B.V. Has $6.54 Million Position in Aetna Inc. (AET)
Robeco Institutional Asset Management B.V. increased its stake in shares of Aetna Inc. (NYSE:AET) by 65.7% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 43,067 shares of the company’s stock after buying an additional 17,073 shares during the period. Robeco Institutional Asset Management B.V.’s holdings in Aetna were worth $6,538,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. Family Firm Inc. bought a new position in shares of Aetna during the second quarter valued at $263,000. Usca Ria LLC bought a new position in shares of Aetna during the second quarter valued at $3,102,000. Parallel Advisors LLC increased its position in shares of Aetna by 9.7% in the second quarter. Parallel Advisors LLC now owns 2,366 shares of the company’s stock valued at $365,000 after buying an additional 209 shares during the period. Mastrapasqua Asset Management Inc. bought a new position in shares of Aetna during the second quarter valued at $1,450,000. Finally, Meiji Yasuda Asset Management Co Ltd. increased its position in shares of Aetna by 1.4% in the second quarter. Meiji Yasuda Asset Management Co Ltd. now owns 22,407 shares of the company’s stock valued at $3,402,000 after buying an additional 300 shares during the period. Institutional investors own 89.57% of the company’s stock.
Shares of Aetna Inc. (NYSE AET) opened at 157.70 on Friday. The firm has a market capitalization of $52.37 billion, a price-to-earnings ratio of 35.01 and a beta of 0.54. Aetna Inc. has a 52 week low of $104.59 and a 52 week high of $161.69. The firm’s 50-day moving average price is $155.55 and its 200 day moving average price is $142.65.
Aetna (NYSE:AET) last released its quarterly earnings results on Thursday, August 3rd. The company reported $3.42 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.34 by $1.08. Aetna had a net margin of 2.52% and a return on equity of 20.52%. The firm had revenue of $15.52 billion during the quarter, compared to the consensus estimate of $15.34 billion. During the same quarter last year, the firm earned $2.21 earnings per share. The company’s revenue for the quarter was down 2.7% on a year-over-year basis. On average, analysts anticipate that Aetna Inc. will post $9.54 EPS for the current year.
WARNING: “Robeco Institutional Asset Management B.V. Has $6.54 Million Position in Aetna Inc. (AET)” was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this piece on another publication, it was copied illegally and reposted in violation of U.S. & international copyright & trademark law. The original version of this piece can be viewed at https://www.thecerbatgem.com/2017/09/01/robeco-institutional-asset-management-b-v-has-6-54-million-position-in-aetna-inc-aet.html.
A number of analysts recently weighed in on the company. Morgan Stanley lifted their price target on Aetna from $172.00 to $179.00 and gave the company an “overweight” rating in a research note on Thursday, August 17th. Cantor Fitzgerald restated an “overweight” rating and issued a $175.00 price target (up from $150.00) on shares of Aetna in a research note on Wednesday, August 9th. Deutsche Bank AG lifted their price target on Aetna from $157.00 to $163.00 and gave the company a “hold” rating in a research note on Monday, August 7th. Jefferies Group LLC restated a “hold” rating and issued a $163.00 price target (up from $157.00) on shares of Aetna in a research note on Friday, August 4th. Finally, Royal Bank Of Canada lifted their price target on Aetna from $162.00 to $171.00 and gave the company an “outperform” rating in a research note on Friday, August 4th. Seven research analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $157.99.
In related news, EVP Margaret M. Mccarthy sold 27,028 shares of Aetna stock in a transaction on Wednesday, June 7th. The shares were sold at an average price of $149.23, for a total transaction of $4,033,388.44. Following the completion of the transaction, the executive vice president now owns 33,563 shares of the company’s stock, valued at $5,008,606.49. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 0.90% of the stock is owned by company insiders.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Receive News & Stock Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related stocks with our FREE daily email newsletter.